153 related articles for article (PubMed ID: 2783491)
1. Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.
Hubbard RC; Casolaro MA; Mitchell M; Sellers SE; Arabia F; Matthay MA; Crystal RG
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):680-4. PubMed ID: 2783491
[TBL] [Abstract][Full Text] [Related]
2. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
3. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
Hubbard RC; Crystal RG
Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
[TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
Hubbard RC; Brantly ML; Sellers SE; Mitchell ME; Crystal RG
Ann Intern Med; 1989 Aug; 111(3):206-12. PubMed ID: 2787611
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.
Buhl R; Vogelmeier C; Critenden M; Hubbard RC; Hoyt RF; Wilson EM; Cantin AM; Crystal RG
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4063-7. PubMed ID: 2349219
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
Smith RM; Traber LD; Traber DL; Spragg RG
J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
[TBL] [Abstract][Full Text] [Related]
7. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
[TBL] [Abstract][Full Text] [Related]
8. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
[TBL] [Abstract][Full Text] [Related]
9. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
10. Aerosolization of superoxide dismutase. Augmentation of respiratory epithelial lining fluid antioxidant screen by aerosolization of recombinant human Cu++/Zn++ superoxide dismutase.
Gillissen A; Roum JH; Hoyt RF; Crystal RG
Chest; 1993 Sep; 104(3):811-5. PubMed ID: 8396002
[TBL] [Abstract][Full Text] [Related]
11. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of lung antineutrophil elastase capacity with recombinant human alpha-1-antitrypsin.
Casolaro MA; Fells G; Wewers M; Pierce JE; Ogushi F; Hubbard R; Sellers S; Forstrom J; Lyons D; Kawasaki G
J Appl Physiol (1985); 1987 Nov; 63(5):2015-23. PubMed ID: 3500941
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.
Borok Z; Gillissen A; Buhl R; Hoyt RF; Hubbard RC; Ozaki T; Rennard SI; Crystal RG
Am Rev Respir Dis; 1991 Nov; 144(5):1080-4. PubMed ID: 1952435
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis.
Martin SL; Downey D; Bilton D; Keogan MT; Edgar J; Elborn JS;
Pediatr Pulmonol; 2006 Feb; 41(2):177-83. PubMed ID: 16372352
[TBL] [Abstract][Full Text] [Related]
15. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
[TBL] [Abstract][Full Text] [Related]
17. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
[TBL] [Abstract][Full Text] [Related]
18. Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Togami K; Chono S; Morimoto K
J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):110-5. PubMed ID: 22360316
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
